Home › Colorectal Cancer › NCT04812912
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
The Effects of Chemotherapy or Radiotherapy on Reproductive and Sexual Health of Early Onset Colorectal Cancer Patients
Who can join
Ages 18 to 50 · All sexes
Full eligibility criteria
Inclusion Criteria: * 18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis * Histologic diagnosis of colorectal adenocarcinoma * Able and willing to participate in the informed consent process * Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer * Willing and able to complete protocol questionnaires * Rectal patients only: Individuals who will be receiving chemotherapy, followed by chemoradiotherapy (ChemoRT) Exclusion Criteria: * Prior systemic treatment for this malignancy * Active or prior secondary malignancy * History of ovarian resection (if female) * Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception until the termination of gestation, confirmed by a positive hCG laboratory test.
About the study
The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in people with early onset colorectal cancer. This information will help researchers know more about how cancer treatments affect reproductive and sexual health, including the ability to have children (fertility).
What is being tested
- Hormone biomarker analysis (diagnostic test)
- QoL Questionnaires (behavioral)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 120 · Started: Mar 18, 2021
Contact the study team
- Andrea Cercek, MD · Phone: 646-888-4189
- Paul Romesser, MD · Phone: 646-888-2118
Official record on ClinicalTrials.gov — NCT04812912
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.